Literature DB >> 18189335

A ligand-pseudoreceptor system based on de novo designed peptides for the generation of adenoviral vectors with altered tropism.

Yue Zeng1, Maxime Pinard, Jaïro Jaime, Lucie Bourget, Phuong Uyen Le, Maureen D O'Connor-McCourt, Rénald Gilbert, Bernard Massie.   

Abstract

BACKGROUND: Delivery of transgenes into specific tissues by adenovirus vectors (AdVs) relies on ablations of their natural tropism and on introduction of a new tropism. If the interaction with its natural receptor is ablated, a new packaging cell line is required to produce the AdV. In the present study, we have used two de novo designed peptides (E-Coil and K-Coil) that interact with each other with high affinity to establish a new receptor-ligand system for the propagation of retargeted AdVs.
METHODS: We produced a cell line (293E) expressing on its surface a pseudoreceptor containing the E-Coil. An AdV (AdFK4m/GFP) lacking the interaction with the primary receptor for adenovirus (CAR) and containing the K-Coil inserted at the fiber C-terminus was constructed and tested using two strategies: (1) an RGD motif (Arg-Gly-Asp) was inserted into the HI-loop of the fiber; (2) AdFK4m/GFP was conjugated to a bispecific adaptor for the epidermal growth factor receptor (EGFR).
RESULTS: AdFK4m/GFP infected 293E cells more efficiently than cells lacking the pseudoreceptor. The transduction was due to the K-Coil/E-Coil specific interaction since it was competed by addition of soluble K-Coil, but not soluble fiber. We demonstrated that the modified AdV was retargeted toward alpha v integrin by inclusion of the RGD motif, or toward EGFR using the bispecific adaptor.
CONCLUSIONS: We have established a new system to produce AdVs ablated of natural tropism. This system should permit the retargeting of AdVs by inserting new ligands within the fiber or through the interaction with bispecific adaptors. (c) 2008 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18189335     DOI: 10.1002/jgm.1155

Source DB:  PubMed          Journal:  J Gene Med        ISSN: 1099-498X            Impact factor:   4.565


  5 in total

1.  Epithelial junction opener JO-1 improves monoclonal antibody therapy of cancer.

Authors:  Ines Beyer; Ruan van Rensburg; Robert Strauss; ZongYi Li; Hongjie Wang; Jonas Persson; Roma Yumul; Qinghua Feng; Hui Song; Jiri Bartek; Pascal Fender; André Lieber
Journal:  Cancer Res       Date:  2011-10-11       Impact factor: 12.701

2.  In vitro and in vivo properties of adenovirus vectors with increased affinity to CD46.

Authors:  Hongjie Wang; Ying Liu; Zongyi Li; Sebastian Tuve; Daniel Stone; Oleksandr Kalyushniy; Dmitry Shayakhmetov; Christophe L M Verlinde; Thilo Stehle; John McVey; Andrew Baker; Kah-Whye Peng; Steve Roffler; André Lieber
Journal:  J Virol       Date:  2008-08-27       Impact factor: 5.103

3.  Structural and functional studies on the interaction of adenovirus fiber knobs and desmoglein 2.

Authors:  Hongjie Wang; Roma Yumul; Hua Cao; Liang Ran; Xiaolong Fan; Maximilian Richter; Forrest Epstein; Julie Gralow; Chloe Zubieta; Pascal Fender; André Lieber
Journal:  J Virol       Date:  2013-08-14       Impact factor: 5.103

4.  Increasing the efficacy of oncolytic adenovirus vectors.

Authors:  Karoly Toth; William S M Wold
Journal:  Viruses       Date:  2010-08-27       Impact factor: 5.818

5.  Fluorescent labeling in semi-solid medium for selection of mammalian cells secreting high-levels of recombinant proteins.

Authors:  Antoine W Caron; Claire Nicolas; Bruno Gaillet; Ismaïla Ba; Maxime Pinard; Alain Garnier; Bernard Massie; Rénald Gilbert
Journal:  BMC Biotechnol       Date:  2009-05-11       Impact factor: 2.563

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.